OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diminished cell proliferation promotes natural killer cell adaptive-like phenotype by limiting FcεRIγ expression
Avishai Shemesh, Yapeng Su, Daniel R. Calabrese, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 11
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Cellular and molecular biomarkers of long COVID: a scoping review
Estefanía Espín, Chengliang Yang, Casey P. Shannon, et al.
EBioMedicine (2023) Vol. 91, pp. 104552-104552
Open Access | Times Cited: 66

ITAM‐based receptors in natural killer cells
Oscar A. Aguilar, Lam‐Kiu Fong, Lewis L. Lanier
Immunological Reviews (2024) Vol. 323, Iss. 1, pp. 40-53
Closed Access | Times Cited: 7

Activating NKG2C Receptor: Functional Characteristics and Current Strategies in Clinical Applications
Jagoda Siemaszko, Aleksandra Marzec-Przyszlak, Katarzyna Bogunia‐Kubik
Archivum Immunologiae et Therapiae Experimentalis (2023) Vol. 71, Iss. 1
Open Access | Times Cited: 14

Expression and regulatory characteristics of peripheral blood immune cells in primary Sjögren’s syndrome patients using single-cell transcriptomic
Jinkun Liu, Hongyan Gao, Chengyin Li, et al.
iScience (2022) Vol. 25, Iss. 12, pp. 105509-105509
Open Access | Times Cited: 19

Susceptibility of Diabetic Patients to COVID-19 Infections: Clinico-Hematological and Complications Analysis
Banan Atwah, Mohammad Shahid Iqbal, Saeed Kabrah, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 561-561
Open Access | Times Cited: 12

Integrative systems biology reveals NKG2A-biased immune responses correlate with protection in infectious disease, autoimmune disease, and cancer
Daniel Chen, Jingyi Xie, Jongchan Choi, et al.
Cell Reports (2024) Vol. 43, Iss. 3, pp. 113872-113872
Open Access | Times Cited: 4

Interleukin-2 is required for NKp30-dependent NK cell cytotoxicity by preferentially regulating NKp30 expression
Nayoung Kim, Eunbi Yi, Eunbi Lee, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4

CITE-Seq Analysis Reveals a Differential Natural Killer Cell SPON2 Expression in Cardiovascular Disease Patients Impacted by Human-Cytomegalovirus Serostatus and Diabetes
Sujit Silas Armstrong Suthahar, Daniel Chen, Sunil Kumar, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1369-1369
Open Access

Coordinated Loss and Acquisition of NK Cell Surface Markers Accompanied by Generalized Cytokine Dysregulation in COVID-19
Maria O. Ustiuzhanina, Julia D. Vavilova, A. A. Boyko, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1996-1996
Open Access | Times Cited: 10

BCG priming followed by a novel interleukin combination activates Natural Killer cells to selectively proliferate and become anti-tumour long-lived effectors
María-José Felgueres, Gloria Esteso, Álvaro F. García-Jiménez, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3

Natural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1
Aljawharah Alrubayyi, Emma Touizer, Dan Hameiri‐Bowen, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8

NKG2D receptor activation drives primary graft dysfunction severity and poor lung transplantation outcomes
Daniel R. Calabrese, Tasha Tsao, Mélia Magnen, et al.
JCI Insight (2022) Vol. 7, Iss. 24
Open Access | Times Cited: 13

Age-dependent NK cell dysfunctions in severe COVID-19 patients
Cinzia Fionda, Silvia Ruggeri, Giuseppe Sciumè, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11

Autologous T-Cell-Free Antigen Presentation System Unveils hCMV-Specific NK Cell Response
Maria O. Ustiuzhanina, Maria A. Streltsova, Nikita D. Timofeev, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 530-530
Open Access | Times Cited: 2

NK Cells: Not Just Followers But Also Initiators of Chronic Vascular Rejection
Mathilde Chambon, Alice Koenig
Transplant International (2024) Vol. 37
Open Access | Times Cited: 2

CCR5 drives NK cell–associated airway damage in pulmonary ischemia-reperfusion injury
Jesse Santos, Ping Wang, Avishai Shemesh, et al.
JCI Insight (2023) Vol. 8, Iss. 21
Open Access | Times Cited: 6

The CD56−CD16+ NK cell subset in chronic infections
Alexander T.H. Cocker, Lisbeth A. Guethlein, Peter Parham
Biochemical Society Transactions (2023) Vol. 51, Iss. 3, pp. 1201-1212
Closed Access | Times Cited: 5

Metabolomic and gut microbiome profiles across the spectrum of community-based COVID and non-COVID disease
Marc F. Österdahl, Ronan Whiston, Carole H. Sudre, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4

HLA-DR Expression in Natural Killer Cells Marks Distinct Functional States, Depending on Cell Differentiation Stage
Sofya A. Kust, Maria O. Ustiuzhanina, Maria A. Streltsova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4609-4609
Open Access | Times Cited: 1

Patients’ Post-/Long-COVID Symptoms, Vaccination and Functional Status—Findings from a State-Wide Online Screening Study
Sonia Lippke, Robin Rinn, Christina Derksen, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 691-691
Open Access | Times Cited: 3

Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIV
Márton Kolossváry, Christopher R. deFilippi, Sara McCallum, et al.
EBioMedicine (2023) Vol. 90, pp. 104538-104538
Open Access | Times Cited: 3

The landscape of abnormal pathway activation confers COVID-19 patients' molecular sequelae earlier than clinical phenotype
Xiuli Zhang, Yuan Sh, Jierong Dong, et al.
Theranostics (2023) Vol. 13, Iss. 10, pp. 3451-3466
Open Access | Times Cited: 2

NK Cells from Human Cytomegalovirus–Seropositive Individuals Have a Distinct Metabolic Profile That Correlates with Elevated mTOR Signaling
John R. Lozada, Bin Zhang, Jeffrey S. Miller, et al.
The Journal of Immunology (2023) Vol. 211, Iss. 4, pp. 539-550
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top